| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0073 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0074 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |